Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies

Peer Review reports

Original Submission
16 Jul 2013	Submitted	Original manuscript
18 Jul 2013	Author responded	Author comments - Asres Berhan
29 Jul 2013	Reviewed	Reviewer Report - Eugen Feist
Resubmission - Version 2
18 Jul 2013	Submitted	Manuscript version 2
Publishing
25 Nov 2013	Editorially accepted
26 Nov 2013	Article published	10.1186/1471-2474-14-332

Back to article page